Related Experiment Videos
Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis
Kathleen Azzam-Smoak1, Diana L Noah, Michael J Stewart
1Department of Microbiology, College of Veterinary Medicine, North Carloina State University, Raleigh 27606, USA.
Virology
|July 3, 2002
Summary
Interferon regulatory factor-1 (IRF-1) plays a protective role against reovirus-induced viral myocarditis. This study shows IRF-1 is not directly induced by viruses but is downstream of the interferon-beta response.
Area of Science:
- Virology
- Immunology
- Cardiology
Background:
- Viral myocarditis is a significant human disease.
- Reovirus-induced myocarditis in mice models direct viral heart damage.
- Interferon regulatory factor-3 (IRF-3) is crucial for reovirus-induced interferon-beta (IFN-beta) in cardiac myocytes.
Purpose of the Study:
- To investigate the role of interferon regulatory factor-1 (IRF-1) in reovirus-induced myocarditis.
- To determine if viral induction of IRF-1 is direct or mediated by IFN-beta.
- To elucidate the protective mechanisms of IRF-1 against viral myocarditis.
Main Methods:
- Primary cardiac myocyte cultures were used to study reovirus-IRF-1 interactions.
- IFN-beta response was modulated to assess its effect on IRF-1 induction.
- Mice deficient for IRF-1 were used to evaluate its role in vivo cardiac lesions.
Main Results:
- Reovirus induced IRF-1 in cardiac myocytes, but IRF-1 was not required for IFN-beta induction.
- Reovirus failed to induce IRF-1 in the absence of the IFN-alpha/beta response, suggesting indirect induction.
- Mice deficient for IRF-1 exhibited increased cardiac lesions from nonmyocarditic reovirus strains.
Conclusions:
- IRF-1 induction by reovirus is downstream of the IFN-beta response, not directly virus-induced.
- IRF-1 plays a critical protective role against viral myocarditis.
- Understanding IRF-1's role offers potential therapeutic targets for viral heart disease.